Adjuvant Immunotherapy: Clinical Trials

2 trials of Adjuvant Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Unknown 1

Follow Adjuvant Immunotherapy: new trials by email Literature Review of Adjuvant Immunotherapy trials Research Report on Adjuvant Immunotherapy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base
Neoadjuvant chemoimmunotherapy, Tislelizumab Nab paclitaxel - Head and Neck Cancer Squamous Cell Carcinoma, Skull Base--Cancer
Phase 2Not yet recruitingSun Yat-sen University242025-09-202025-08-28
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
endoscopic surgery - Recurrent Nasopharyngeal Carcinoma
Phase 2UnknownEye & ENT Hospital of Fudan University772022-05-082022-05-10

Conditions studied

Nasopharyngeal Carcinoma (1)

Sponsors

Eye & ENT Hospital of Fudan University (1)  ·  Sun Yat-sen University (1)

Countries

China (2)

Top investigators

Hongmeng Yu, MD,PHD (1)  ·  Yujie Liang (1)

Results publications

PMID 15825201, PMID 18486742, PMID 18784101, PMID 23129742, PMID 27718784, PMID 30509740, PMID 31679945, PMID 33243985, PMID 34473219, PMID 35585121, PMID 35766967, PMID 37395170, PMID 37991778, PMID 38110599, PMID 38467604